Inhibitory Antibodies
Product Name | CAS No. | Specification | Application | Registration |
Aflibercept | 862111-32-8 | 95+% | ||
Anakinra (IL-1Ra) | 143090-92-0 | 98+% | Rheumatoid Arthritis | |
Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | Antineoplastic Agent | |
Cetuximab (C225) | 205923-56-4 | 95+% | Antineoplastic Agent | |
Etanercept | 185243-69-0 | 95+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks